Translational Development Acquisition Corp.
TDAC · XNASCIK 1926599fmd_0CA2MV1D91XM2ZPRCQ9R9PW0Q6Finance, Insurance and Real Estate · Blank ChecksTemplate: Standard
Coverage: Jan 01, 2023 to Jun 30, 2026, 11 periods
Latest annual · FY2025
Millions- Operating income
- (1)
- Net income
- 6
Latest quarter · Q2 FY2026
Millions- Operating income
- (1)
- Net income
- 1
Daily close · TDACIEX trades only
Apr 28, 2025 to Oct 21, 2026 · 51 sessions10.82 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Translational Development Acquisition Corp. (TDAC) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$944,538 | -$196,358 | 10-K 2026-03-30 · proof | |
| Net income | $6.4 million | -$71,012 | 10-K 2026-03-30 · proof | |
| Cash from operating activities | -$608,387 | -$851,446 | 10-K 2026-03-30 · proof | |
| Total assets | $181.7 million | $175 million | +3.8% | 10-K 2026-03-30 · proof |
| Total liabilities | $6.6 million | $6.2 million | +5.3% | 10-K 2026-03-30 · proof |
| Cash and cash equivalents | $29,787 | $438,174 | -93.2% | 10-K 2026-03-30 · proof |
- What was Translational Development Acquisition Corp. (TDAC)'s operating income in fiscal 2025?
- Translational Development Acquisition Corp. (TDAC) reported operating income of -$944,538 for fiscal 2025 (the year ended Dec 31, 2025), against -$196,358 the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Translational Development Acquisition Corp. (TDAC)'s net income in fiscal 2025?
- Translational Development Acquisition Corp. (TDAC) reported net income of $6.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$71,012 the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Translational Development Acquisition Corp. (TDAC)'s cash from operating activities in fiscal 2025?
- Translational Development Acquisition Corp. (TDAC) reported cash from operating activities of -$608,387 for fiscal 2025 (the year ended Dec 31, 2025), against -$851,446 the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Translational Development Acquisition Corp. (TDAC)'s total assets?
- As of Dec 31, 2025, Translational Development Acquisition Corp. (TDAC) reported total assets of $181.7 million, against $175 million a year earlier (+3.8%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Translational Development Acquisition Corp. (TDAC)'s total liabilities?
- As of Dec 31, 2025, Translational Development Acquisition Corp. (TDAC) reported total liabilities of $6.6 million, against $6.2 million a year earlier (+5.3%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Translational Development Acquisition Corp. (TDAC)'s cash and cash equivalents?
- As of Dec 31, 2025, Translational Development Acquisition Corp. (TDAC) reported cash and cash equivalents of $29,787, against $438,174 a year earlier (-93.2%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:TDAC&period_type=annual&limit=5"Information only, not investment advice.